<DOC>
	<DOCNO>NCT01112137</DOCNO>
	<brief_summary>Context : Soluble CD40 ligand ( sCD40L ) release activated platelet induce inflammatory transformation vascular endothelium independent predictor cardiovascular event . Arterial hypertension associate platelet activation , increase sCD40L level endothelial dysfunction suggest inhibition platelet-derived sCD40L release may improve endothelial function lower blood pressure ( BP ) . Objective : To determine effect clopidogrel sCD40L , endothelial function BP . Design : Randomized , control , investigator-blinded , parallel-group , 2-phase trial patient coronary artery disease essential arterial hypertension without hypertension . Intervention : Participants receive single 600-mg clopidogrel load dose ( phase I ) follow daily 75-mg clopidogrel maintenance dose 28 day ( phase II ) . Outcome Measures : Primary outcome measure change BP baseline . Secondary outcome measure change biomarkers platelet endothelial function correlation BP .</brief_summary>
	<brief_title>Effects Clopidogrel Blood Pressure</brief_title>
	<detailed_description />
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<criteria>Patients coronary artery disease ( CAD ) clinical presentation stable angina pectoris acute coronary syndrome undergone percutaneous coronary intervention ( PCI ) stent implantation 5year history essential arterial hypertension systolic BP 140 170 mmHg hypertension ( systolic BP &lt; 140mg Hg diastolic BP &lt; 90 mmHg ) treatment clopidogrel ( 75 mg per day ) 6 12 month PCI continuous use aspirin ( 100 mg per day ) change drug therapy within 3 month prestudy stent thrombosis another ischemic cardiovascular event follow PCI use antiplatelet drug anticoagulant within 3 month prestudy surgery within 3 month prestudy arrhythmia valvular heart disease hematologic disorder severe renal disorder severe hepatic disorder chronic inflammatory disorder autoimmune disorder acute chronic infection active malignancy bodymass index 18.5 40 kg/m2 nonadherence therapy nonattendance control visit</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2010</verification_date>
</DOC>